Abstract Background Brain metastases (BrM) incidence is 25% to 50% in women with
advanced human epidermal growth factor receptor 2 (HER2)‐positive breast cancer …

Opinion statement Radiation-induced cognitive decline in cancer survivors who have
received brain radiotherapy is an insidious problem with worsening severity over time …

Purpose Prior statistical models attempted to identify risk factors for time to distant brain
failure (DBF) or time to salvage whole-brain radiation therapy (WBRT) to predict the benefit …

The risk factors for morbidity and mortality in breast cancer lung metastases (BCLM) patients
still remain poorly identified. The aim of this study was to assess the incidence and survival …

Background The effect of immunotherapy on brain metastasis patients remains incompletely
understood. Our goal was to evaluate its effect on survival, neurologic death, and patterns of …

Background The incidence of brain metastasis continues to increase as therapeutic
strategies have improved for a number of solid tumors. The presence of brain metastasis is …

Background We review our single institution experience to determine predictive factors for
early and delayed distant brain failure (DBF) after radiosurgery without whole brain …

Background. In this study we attempted to discern the factors predictive of neurologic death
in patients with brain metastasis treated with upfront stereotactic radiosurgery (SRS) without …

Brain metastases occur in up to 25–55% of patients with metastatic HER2-positive breast
cancer. Standard treatment has high rates of recurrence or progression, limiting survival and …

Purpose To assess effectiveness and toxicity levels of stereotactic radiation therapy without
whole brain radiation therapy in patients with solitary brain metastases larger than 3 cm …